Aug. 3 at 3:59 PM
$KURA - It is No brainer tha Kyowa Kirin is interested in buying Kura, as they now have approval and phase 3 trials are well underway to expand indiacation for their partnered drug, and now Kura has their fully own drugs also progressing well in combination trials with good results.
Now it is matter of TIME...
Kyowa must be trying to buy now (and may be that is why the range bound stock price and keeping under
$10) so they can offer 100% premium, and Kura (CEO) want to get higher price - may be around
$30 or 30+ given their progress, cash runway and trials going on etc.
Not sure when, but BO will happen!!! (in few weeks or couple months or next Year latest).
Given the recent change in some terms for severance package and wasting etc for executives, I think BO is coming sooner that later.
Very Bullish at this price (almost cash value).
